MX2009007774A - Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros. - Google Patents

Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.

Info

Publication number
MX2009007774A
MX2009007774A MX2009007774A MX2009007774A MX2009007774A MX 2009007774 A MX2009007774 A MX 2009007774A MX 2009007774 A MX2009007774 A MX 2009007774A MX 2009007774 A MX2009007774 A MX 2009007774A MX 2009007774 A MX2009007774 A MX 2009007774A
Authority
MX
Mexico
Prior art keywords
polymers
compositions containing
ophthalmic compositions
synergistic combination
ophthalmic
Prior art date
Application number
MX2009007774A
Other languages
English (en)
Inventor
Huagang Chen
Masood A Chowhan
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MX2009007774A publication Critical patent/MX2009007774A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones oftálmicas apropiadas para uso como lágrimas artificiales o como vehículos para drogas oftálmicas. Las composiciones contienen una combinación de tres polímeros que tienen un efecto sinergístico sobre la viscosidad.
MX2009007774A 2007-02-09 2008-02-08 Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros. MX2009007774A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88897507P 2007-02-09 2007-02-09
PCT/US2008/053378 WO2008100807A2 (en) 2007-02-09 2008-02-08 Ophthalmic compositions containing a synergistic combination of three polymers

Publications (1)

Publication Number Publication Date
MX2009007774A true MX2009007774A (es) 2009-07-31

Family

ID=39402554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007774A MX2009007774A (es) 2007-02-09 2008-02-08 Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.

Country Status (13)

Country Link
US (1) US20080193407A1 (es)
EP (1) EP2109442B1 (es)
JP (2) JP5431965B2 (es)
KR (1) KR101555291B1 (es)
CN (1) CN101605531B (es)
AU (1) AU2008216497B2 (es)
BR (1) BRPI0806967A2 (es)
CA (1) CA2675601C (es)
ES (1) ES2460570T3 (es)
MX (1) MX2009007774A (es)
PL (1) PL2109442T3 (es)
WO (1) WO2008100807A2 (es)
ZA (1) ZA200904917B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110134525A (ko) * 2003-06-13 2011-12-14 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US9636355B2 (en) * 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
DE102014007423A1 (de) * 2014-05-22 2015-11-26 Bitop Ag Zusammensetzung zur Behandlung des Auges
RU2576778C1 (ru) * 2015-02-20 2016-03-10 Илья Александрович Марков Фармацевтическая композиция в виде гелеобразных глазных капель для лечения глаукомы
AU2017275492A1 (en) * 2016-06-01 2018-12-20 Harold Richard Hellstrom Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
KR102051356B1 (ko) * 2019-01-03 2019-12-03 (주)휴온스 고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
TWI826685B (zh) * 2019-05-02 2023-12-21 瑞士商愛爾康公司 可溶解聚合物眼睛插入物及其使用方法
WO2023214027A1 (en) * 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
BE1030504B1 (fr) * 2022-05-06 2023-12-04 Eyed Pharma Insert composite pour le traitement de la sécheresse oculaire
BE1030503B1 (fr) * 2022-05-06 2023-12-04 Eyed Pharma Insert pour le traitement de la sécheresse oculaire
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) * 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5368843A (en) * 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
CA2134376C (en) 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
ES2116681T3 (es) * 1994-03-18 1998-07-16 Senju Pharma Co Preparaciones oftalmicas para reducir la presion intraocular.
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
CN100408100C (zh) * 1997-07-29 2008-08-06 阿尔康实验室公司 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
CA2264290C (en) * 1997-07-29 2005-11-29 Alcon Laboratories, Inc. Conditioning solutions for contact lens care
US7001615B1 (en) * 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
AU2003213210A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
WO2004091578A2 (en) * 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Novel encochleation methods, cochleates and methods of use
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
KR20110134525A (ko) * 2003-06-13 2011-12-14 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers

Also Published As

Publication number Publication date
AU2008216497B2 (en) 2013-09-26
PL2109442T3 (pl) 2014-07-31
KR20090108092A (ko) 2009-10-14
AU2008216497A1 (en) 2008-08-21
US20080193407A1 (en) 2008-08-14
CA2675601A1 (en) 2008-08-21
JP2010518116A (ja) 2010-05-27
ES2460570T3 (es) 2014-05-13
CN101605531A (zh) 2009-12-16
WO2008100807A3 (en) 2008-12-24
CN101605531B (zh) 2012-10-10
EP2109442A2 (en) 2009-10-21
WO2008100807A2 (en) 2008-08-21
JP5431965B2 (ja) 2014-03-05
JP2014040474A (ja) 2014-03-06
EP2109442B1 (en) 2014-03-26
CA2675601C (en) 2016-06-21
KR101555291B1 (ko) 2015-09-30
ZA200904917B (en) 2010-09-29
BRPI0806967A2 (pt) 2014-04-08

Similar Documents

Publication Publication Date Title
MX2009007774A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.
MXPA05013290A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros.
TW200501969A (en) Ophthalmic compositions containing a synergistic combination of three polymers
PH12015501737A1 (en) Androgen receptor modulators and uses thereof
WO2012037410A3 (en) Estrogen receptor modulators and uses thereof
WO2011156518A3 (en) Estrogen receptor modulators and uses thereof
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
IN2012DN02984A (es)
WO2011159769A3 (en) Indane estrogen receptor modulators and uses thereof
IN2012DN02735A (es)
IN2012DN02702A (es)
WO2008154143A3 (en) Elastomeric copolymer coatings for implantable medical devices
WO2008066630A3 (en) Methods for reprogramming adult somatic cells and uses thereof
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
MX2009008364A (es) Sal de napadisilato de un antagonista m3 muscarinico.
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
UA100393C2 (ru) Новые офтальмологические композиции
WO2009102707A3 (en) Substituted oxazaphosphorines
IL201148A0 (en) Device for the delivery of viscous compositions
MY165088A (en) Pharmaceutical compositions comprising alisporivir
MX2022011310A (es) Azabiciclo y derivados de diazepina para tratar trastornos oculares.
PL1996157T3 (pl) Oftalmiczna kompozycja farmaceutyczna zawierająca amfifilowe kopolimery poliaspartamidu
WO2008124524A3 (en) Aryl sulfonamide compounds as modulators of the cck2 receptor
WO2008112701A3 (en) G-substrate for the treatment and prevention of parkinson's disease
UA27344U (en) Use of pollentar pharmaceutical composition as cerebroprotective agent

Legal Events

Date Code Title Description
FG Grant or registration